Volume 19, Number 8—August 2013
Novel G10P Rotavirus Strain, Northern Territory, Australia
|Case-patient specimen ID||Case-patient age||Date specimen collected||Location (postal code) of specimen collection†||Rotavirus vaccine (no. doses)‡|
|V582||8 mo||Aug 13||0860||Rotarix (2)|
|WDP280||10 mo||Aug 19||0872||Rotarix (2)|
|V585||2 y||Aug 19||0860||Rotarix (2)|
|SA175||3 mo||Sep 2||Unknown||Unknown|
|SA179||4 mo||Sep 6||0872||Rotarix (1)|
|D355||84 y||Sep 11||0860||Not applicable|
†Postal code zone 0860 encompasses Tennant Creek, Northern Territory; samples WDP280 and SA179 were collected in post code zone 0872, in communities near code zone 0860.
‡Rotarix, Glaxo SmithKlineBiologicals, Melbourne, Victoria, Australia.
1These authors contributed equally to this article.
- Page created: July 19, 2013
- Page last updated: July 19, 2013
- Page last reviewed: July 19, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)